Stephen Machatha - Feb 28, 2023 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Chief Development Officer
Signature
/s/ Stephen Machatha
Stock symbol
ALDX
Transactions as of
Feb 28, 2023
Transactions value $
$0
Form type
4
Date filed
3/2/2023, 03:27 PM
Previous filing
Jul 19, 2022
Next filing
Mar 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (right to buy) Award $0 +220K $0.00 220K Feb 28, 2023 Common Stock 220K $6.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2023.